Skip to Main Content


Everyone (Public)

7th Annual Schottenfeld Lecture: Integrating Addiction Treatment in HIV Clinical Settings: Efforts to Move the Needle and Lessons Learned

The Yale Program in Addiction Medicine is pleased to welcome E. Jennifer Edelman, MD, MHS, as speaker for the 7th Annual Schottenfeld Lecture.

This event will be held in a hybrid in-person and virtual format. To attend virtually, please register using the registration link provided on this event page.

Title: Integrating Addiction Treatment in HIV Clinical Settings: Efforts to Move the Needle and Lessons Learned

Learning Objectives:

  1. Recognize gaps in substance use disorder (SUD) treatment among individuals with HIV
  2. Identify evidence-based approaches to addressing SUD in HIV clinical settings
  3. Describe innovative strategies to address SUD in HIV clinical settings

    Directions to Boyer 206/208 (295 Congress Avenue, New Haven, CT 06510):

    Enter the main entrance of the Boyer Center for Molecular Medicine, 295 Congress Avenue, take stairs or elevator to 2nd floor, enter BCMM208 through the double glass doors, turn right and right again to enter BCMM206.

    Dr. E. Jennifer Edelman is Professor of Medicine and Public Health. Certified as an internist, HIV specialist and in Addiction Medicine, she serves as an HIV provider and the physician consultant in the Addiction Medicine Treatment Program at the Yale-New Haven Hospital Nathan Smith HIV Clinic. Her research focuses on optimizing HIV prevention and treatment in the context of substance use, including opioid, alcohol and tobacco use. To this end and applying a range of methodologies, she leads and collaborates on NIH-funded projects to evaluate novel and implement evidence-based addiction treatment in medical settings, especially HIV treatment settings. In addition, her work has focused on understanding harms associated with opioid use among people with HIV. She collaborates with community-based and public health partners to promote HIV prevention, including use of pre-exposure prophylaxis (PrEP). She mentors trainees, including post-doctoral fellows and public health students, and is Associate Director of the Research on Addiction Medicine Scholars (RAMS) Program and co-Director of Education at the Yale Center for Clinical Investigation. She regularly serves on NIH grant review committees and is Associate Editor of Addiction Science and Clinical Practice.

    The Schottenfeld Lecture is held each September to acknowledge the contributions of our colleague, Richard Schottenfeld, MD, to the integration of medical care and addiction treatment. Dr. Schottenfeld, an Addiction Psychiatrist and founding Director of the Yale Addiction Psychiatry Residency Training Program, is an experienced clinician, teacher and clinical researcher whose work has focused on improving the efficacy, accessibility, and availability of addiction treatment in the United States and internationally. In the 1980’s and the 1990’s, while at Yale, Richard helped pioneer primary care-based models of care for people who inject drugs. He currently serves at the Chair of Psychiatry at Howard University College of Medicine. In his role as a Professor of Psychiatry at Yale, he was instrumental in supporting and mentoring numerous clinicians and researchers locally and internationally. His work helped lay the foundation for the Yale Program in Addiction Medicine and we are delighted to honor his legacy with the annual Schottenfeld Lecture.

    Addiction Medicine Rounds are CME accredited. Each session will be assigned 1 AMA PRA Category 1 CreditsTM.




    Host Organization




    Lectures and Seminars